“Solution-oriented and brings creative counsel to novel situations”
Who's Who Legal 2022
“Wealth of experience”
Who's Who Legal 2022
“Practical advice”
Who's Who Legal 2022
Profile
Patrick English advises clients on merger control matters, particularly involving the healthcare industry and premerger notification analysis.
Patrick leverages a particular knowledge and passion for the healthcare industry and a nuanced understanding of the regulatory space to guide companies — especially those in the pharmaceutical, life sciences, and medical device sectors — on:
Merger control proceedings before the Federal Trade Commission and Department of Justice
Premerger notification analysis, including under the Hart-Scott-Rodino Act
Internal investigations and compliance programs
He helps clients strategically navigate an evolving antitrust regulatory landscape, while evaluating risk and anticipating issues before they compromise a transaction. Patrick devises creative solutions that allow his clients’ commercial visions to become reality.
A recognized leader both within the firm and in his field, Patrick has served on Latham’s Recruiting Committee, as Local Co-Leader and Global Co-Leader of the LGBTQ+ Affinity Group, and on the Pro Bono Committee. Over the last decade serving in the American Bar Association’s Antitrust Section, he has been Co-Chair of the Membership, Diversity & Inclusion (MD&I) Committee and supported the Section’s Mentoring and Law Student Ambassador programs. In addition, Patrick has served as the leader of the Section’s LGBTQ+ Squad, a Vice Chair of MD&I Committee, a Vice Chair of the Health Care and Pharmaceuticals Committee, and as Young Lawyer Representative for the Health Care and Pharmaceuticals Committee.
He maintains a significant and varied pro bono practice involving multiple areas, including immigration, Social Security benefits, expungements, and human rights. Patrick also serves as Whitman-Walker Health pro bono liaison at Latham. He is a longstanding advocate for Whitman-Walker, having previously held roles as Co-Chair of both the Whitman Walker Health Walk to End HIV Legal Community Campaign and the Steering Committee for Whitman-Walker’s Going the Extra Mile event. In addition to his pro bono work, Patrick was elected to the D.C. Bar Board of Governors in 2023.
Before law school, Patrick spent three years with the Federal Trade Commission (FTC) in its Bureau of Competition, where he focused on mergers in the healthcare and life sciences sectors. He has also served as a Research Fellow for the American Antitrust Institute.
Experience
Patrick's experience includes representing:
Healthcare
Amgen in acquiring Teneobio, a clinical-stage biotechnology company
Amneal Pharmaceuticals in its US$1.4 billion business combination with Impax Laboratories
ANI Pharmaceuticals in obtaining US antitrust clearance to acquire Novitium, a pharmaceuticals company specializing in niche generic products
ArchiMed Group in acquiring Natus Medical, a medical device solutions provider
Arthrocare in its US$1.7 billion merger with Smith & Nephew
Cerner in acquiring Kantar Health, a life sciences and research company
Gavis Pharmaceuticals in its US$880 million sale to Lupin
Grail, an American biotechnology company, in its sale to Illumina
Integra LifeSciences Holdings in its US$1.05 billion acquisition of Johnson & Johnson’s Codman Neurosurgery business
Vitamin Shoppe in its US$50 million acquisition of Super Supplements
Other Merger Control Matters
Cannery Casino Resorts in selling two Las Vegas properties to Boyd Gaming
Entercom Communications in its US$105 million acquisition of Lincoln Financial Media
Leap Wireless in its US$1.2 billion sale to AT&T
Veyance Technologies in its US$1.9 billion acquisition by Continental AG
Qualifications
Bar Qualification
District of Columbia
Education
JD, Northwestern University School of Law, 2009 cum laude
In the leading competition publication’s annual review of the strongest antitrust practices around the globe, the firm dominated in every category, ranking second across all specialties.
Notice: We appreciate your interest in Latham & Watkins. If your inquiry relates to a legal matter and you are not already a current client of the firm, please do not transmit any confidential information to us. Before taking on a representation, we must determine whether we are in a position to assist you and agree on the terms and conditions of engagement with you. Until we have completed such steps, we will not be deemed to have a lawyer-client relationship with you, and will have no duty to keep confidential the information we receive from you. Thank you for your understanding.